Although the 2014 Farm Bill permitted cultivation in some circumstances, CBD was classified as a Schedule 1 drug by the Drug Enforcement Administration (DEA), putting it in the same category as LSD and heroin. Schedule I drug. As a result, the Drug Enforcement Administration removed Epidiolex - but no other forms of CBD - from Schedule I and placed it in Schedule V of the Controlled Substances Act. Endocannabinoids are produced naturally in the body and act as signaling molecules to keep inflammation under control. In fact, a study published in Rheumatology by Dr. David Blake of the Royal National Hospital for Rheumatic Diseases, has showcased cannabis’ direct role in the therapeutic treatment of chronic pain brought on by RA-induced joint inflammation. One of the exciting things about CBD as an emerging RA treatment is the fact that it’s been suggested to have a physiological role as an immune modulator. However, quality research has suggested that it may provide substantial benefits. Below you’ll find how CBD oil works to reduce the symptoms of this autoimmune disease, summaries of the research being done in this space, and general dosage and consumption information, should you decide to try CBD oil as a treatment for your arthritis.